Compound Detail
CHEMBL278020
NEOSTIGMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL278020 |
| Name | NEOSTIGMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ALWKGYPQUAPLQC-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
6
Targets
17
Activities
1
Assay Types
2
PK Parameters
20
Publications
6
Known Names
11
Indications
Molecular Properties
223.3
MW (Da)
1.94
ALogP
2
HBA
0
HBD
29.5
PSA (Ų)
0.72
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2013 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Glaucoma Burns Headache Postoperative Nausea and Vomiting Breast Neoplasms Gastroparesis Hypospadias Kidney Diseases Obesity, Morbid Pain Postoperative Complications
ATC Classification
N07AA01
neostigmine
Level 1: NERVOUS SYSTEM
Level 2: OTHER NERVOUS SYSTEM DRUGS
N07AA51
neostigmine, combinations
Level 1: NERVOUS SYSTEM
Level 2: OTHER NERVOUS SYSTEM DRUGS
S01EB06
neostigmine
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Activity Summary
IC50 17 meas. best 8.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Acetylcholinesterase CHEMBL4780 | IC50 | 8.34 | 8.34 | 4.6 | 1 |
| Acetylcholinesterase CHEMBL4078 | IC50 | 7.72 | 5.2817 | 19.0 | 6 |
| Cholinesterase CHEMBL5763 | IC50 | 6.8 | 5.4275 | 160.0 | 4 |
| Acetylcholinesterase CHEMBL220 | IC50 | 5.62 | 5.135 | 2400.0 | 2 |
| Cholinesterase CHEMBL1914 | IC50 | 4.79 | 4.56 | 16300.0 | 3 |
| Unchecked CHEMBL612545 | IC50 | 4.65 | 4.65 | 22200.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Fu | 0.95 | - | Rattus norvegicus |
| Vd | 3.2 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine